questionsmedicales.fr
Diagnostic
Techniques et procédures diagnostiques
Techniques de diagnostic endocrinien
Tests fonctionnels de l'axe hypophysosurrénalien
Tests fonctionnels de l'axe hypophysosurrénalien : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tests fonctionnels de l'axe hypophysosurrénalien : Questions médicales les plus fréquentes",
"headline": "Tests fonctionnels de l'axe hypophysosurrénalien : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tests fonctionnels de l'axe hypophysosurrénalien : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-19",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tests fonctionnels de l'axe hypophysosurrénalien"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques de diagnostic endocrinien",
"url": "https://questionsmedicales.fr/mesh/D003940",
"about": {
"@type": "MedicalCondition",
"name": "Techniques de diagnostic endocrinien",
"code": {
"@type": "MedicalCode",
"code": "D003940",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.374"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tests fonctionnels de l'axe hypophysosurrénalien",
"alternateName": "Pituitary-Adrenal Function Tests",
"code": {
"@type": "MedicalCode",
"code": "D010912",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zuleyha Karaca",
"url": "https://questionsmedicales.fr/author/Zuleyha%20Karaca",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Fahrettin Kelestimur",
"url": "https://questionsmedicales.fr/author/Fahrettin%20Kelestimur",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Meg Keil",
"url": "https://questionsmedicales.fr/author/Meg%20Keil",
"affiliation": {
"@type": "Organization",
"name": "Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Christina Tatsi",
"url": "https://questionsmedicales.fr/author/Christina%20Tatsi",
"affiliation": {
"@type": "Organization",
"name": "Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Kursad Unluhizarci",
"url": "https://questionsmedicales.fr/author/Kursad%20Unluhizarci",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Integrating Micro and Nano Technologies for Cell Engineering and Analysis: Toward the Next Generation of Cell Therapy Workflows.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36154011",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsnano.2c05494"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent Advances in DNA-Based Cell Surface Engineering for Biological Applications.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/35977912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/chem.202202070"
}
},
{
"@type": "ScholarlyArticle",
"name": "Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering.",
"datePublished": "2023-02-23",
"url": "https://questionsmedicales.fr/article/36828738",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcyt.2023.01.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39334383",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-024-05627-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Highly efficient mRNA delivery with nonlinear microfluidic cell stretching for cellular engineering.",
"datePublished": "2023-03-28",
"url": "https://questionsmedicales.fr/article/36727443",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2lc01115h"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Diagnostic",
"item": "https://questionsmedicales.fr/mesh/D003933"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques et procédures diagnostiques",
"item": "https://questionsmedicales.fr/mesh/D019937"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques de diagnostic endocrinien",
"item": "https://questionsmedicales.fr/mesh/D003940"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tests fonctionnels de l'axe hypophysosurrénalien",
"item": "https://questionsmedicales.fr/mesh/D010912"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tests fonctionnels de l'axe hypophysosurrénalien - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tests fonctionnels de l'axe hypophysosurrénalien",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tests fonctionnels de l'axe hypophysosurrénalien",
"description": "Quels tests évaluent l'axe hypophysosurrénalien ?\nComment interpréter un taux élevé de cortisol ?\nQuel est le rôle du test de stimulation à l'ACTH ?\nQuand réaliser un test de suppression à la dexaméthasone ?\nQuels symptômes justifient ces tests ?",
"url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Cell+Engineering&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tests fonctionnels de l'axe hypophysosurrénalien",
"description": "Quels symptômes indiquent un dysfonctionnement surrénalien ?\nComment reconnaître le syndrome de Cushing ?\nQuels signes d'insuffisance surrénalienne ?\nQuels symptômes d'un excès de cortisol ?\nQuels symptômes d'un déficit en cortisol ?",
"url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Cell+Engineering&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tests fonctionnels de l'axe hypophysosurrénalien",
"description": "Peut-on prévenir les troubles surrénaliens ?\nComment réduire le stress pour protéger les surrénales ?\nL'alimentation influence-t-elle la santé surrénalienne ?\nQuels examens préventifs sont recommandés ?\nComment éviter les médicaments à risque pour les surrénales ?",
"url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Cell+Engineering&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tests fonctionnels de l'axe hypophysosurrénalien",
"description": "Comment traiter le syndrome de Cushing ?\nQuel traitement pour l'insuffisance surrénalienne ?\nQuels médicaments pour réguler le cortisol ?\nComment gérer les effets secondaires des traitements ?\nY a-t-il des traitements naturels pour ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Cell+Engineering&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tests fonctionnels de l'axe hypophysosurrénalien",
"description": "Quelles complications peuvent survenir avec le syndrome de Cushing ?\nQuels risques d'une insuffisance surrénalienne non traitée ?\nComment les troubles surrénaliens affectent-ils la santé mentale ?\nQuelles complications liées aux traitements hormonaux ?\nQuels impacts sur la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Cell+Engineering&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tests fonctionnels de l'axe hypophysosurrénalien",
"description": "Quels facteurs augmentent le risque de syndrome de Cushing ?\nY a-t-il des prédispositions génétiques ?\nComment le stress influence-t-il les troubles surrénaliens ?\nQuels antécédents médicaux sont des facteurs de risque ?\nL'alimentation joue-t-elle un rôle dans ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D010912?mesh_terms=Cell+Engineering&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quels tests évaluent l'axe hypophysosurrénalien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de stimulation à l'ACTH et le test de suppression à la dexaméthasone sont courants."
}
},
{
"@type": "Question",
"name": "Comment interpréter un taux élevé de cortisol ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé peut indiquer un syndrome de Cushing ou une hyperplasie surrénalienne."
}
},
{
"@type": "Question",
"name": "Quel est le rôle du test de stimulation à l'ACTH ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il évalue la capacité des glandes surrénales à produire du cortisol en réponse à l'ACTH."
}
},
{
"@type": "Question",
"name": "Quand réaliser un test de suppression à la dexaméthasone ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est effectué pour diagnostiquer le syndrome de Cushing en vérifiant la réponse au cortisol."
}
},
{
"@type": "Question",
"name": "Quels symptômes justifient ces tests ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme fatigue, prise de poids ou hypertension peuvent nécessiter ces tests."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un dysfonctionnement surrénalien ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, perte de poids, hypotension et troubles de l'humeur sont des signes fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître le syndrome de Cushing ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Obésité centrale, vergetures, et hypertension artérielle sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Quels signes d'insuffisance surrénalienne ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue extrême, hypotension, et hyperpigmentation de la peau."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un excès de cortisol ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent prise de poids, acné, et irrégularités menstruelles chez les femmes."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un déficit en cortisol ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure faiblesse musculaire, nausées et perte d'appétit."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles surrénaliens ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une détection précoce et un suivi médical régulier peuvent aider à prévenir des complications."
}
},
{
"@type": "Question",
"name": "Comment réduire le stress pour protéger les surrénales ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la méditation, le yoga et l'exercice régulier peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé surrénalienne ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments et faible en sucre peut soutenir la santé surrénalienne."
}
},
{
"@type": "Question",
"name": "Quels examens préventifs sont recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bilans hormonaux réguliers peuvent aider à détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "Comment éviter les médicaments à risque pour les surrénales ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les corticostéroïdes non prescrits et consultez toujours un médecin avant tout traitement."
}
},
{
"@type": "Question",
"name": "Comment traiter le syndrome de Cushing ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure la chirurgie, la radiothérapie ou des médicaments pour réduire le cortisol."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'insuffisance surrénalienne ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est le remplacement hormonal avec des corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour réguler le cortisol ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme le kétoconazole ou la mitotane peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel de surveiller régulièrement les effets secondaires et d'ajuster les doses."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour ces troubles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines approches comme la gestion du stress et une alimentation équilibrée peuvent aider."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le syndrome de Cushing ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le diabète, l'hypertension et les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels risques d'une insuffisance surrénalienne non traitée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une crise surrénalienne, potentiellement mortelle sans traitement."
}
},
{
"@type": "Question",
"name": "Comment les troubles surrénaliens affectent-ils la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles de l'humeur, de l'anxiété et des dépressions."
}
},
{
"@type": "Question",
"name": "Quelles complications liées aux traitements hormonaux ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent entraîner des effets secondaires comme l'ostéoporose et le diabète."
}
},
{
"@type": "Question",
"name": "Quels impacts sur la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles surrénaliens peuvent affecter l'énergie, l'humeur et les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de syndrome de Cushing ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le stress chronique et certains médicaments comme les corticostéroïdes sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions génétiques, comme le syndrome de Cushing familial, augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il les troubles surrénaliens ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut perturber la production hormonale et aggraver les troubles surrénaliens."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de maladies endocriniennes ou de traitements hormonaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans ces troubles ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée peut contribuer à des troubles hormonaux et à l'obésité."
}
}
]
}
]
}
The emerging field of cell therapy offers the potential to treat and even cure a diverse array of diseases for which existing interventions are inadequate. Recent advances in micro and nanotechnology ...
Due to its excellent programmability and biocompatibility, DNA molecule has unique advantages in cell surface engineering. Recent progresses provide a reliable and feasible way to engineer cell surfac...
Most current chimeric antigen receptor (CAR) T cells are generated by viral transduction, which induces persistent expression of CARs and may cause serious undesirable effects. Messenger RNA (mRNA)-ba...
The authors designed and engineered an exosome delivery platform using the bacteriophage MS2 system in combination with the highly expressed protein lysosome-associated membrane protein 2 isoform B on...
The authors' delivery platform achieved specific loading and delivery of mRNA into target cells and achieved expression of specific proteins, and anti-CD3/CD28 single-chain variable fragments (scFvs) ...
The delivery of CAR mRNA and anti-CD3/CD28 scFvs via designed exosomes can be used for ex vivo production of CAR T cells with cancer cell killing capacity. The authors' results indicate the potential ...
Apoptosis, a form of programmed cell death, is critical for the development and homeostasis of the immune system. Chimeric antigen receptor T (CAR-T) cell therapy, approved for hematologic cancers, re...
We used a cell-free approach using artificial MitoT (Mitoception) of UC-MSC derived MT to peripheral blood mononuclear cells (PBMCs) followed by RNA-seq analysis of CD3...
Gene expression related to apoptosis, cell death and/or responses to different stimuli was modified in CD3...
Artificial MitoT prevents STS-induced apoptosis of human CD3...
In the past few years, messenger RNA (mRNA) has emerged as a promising therapeutic agent for the treatment and prevention of various diseases. Clinically, mRNA-based drugs have been used for cancer im...
Recent investigations employing animal models have highlighted the significance of microglia as crucial immunological modulators in various neuropsychiatric and physical diseases. Postmortem brain ana...
Colorectal tumours are often densely infiltrated by immune cells that have a role in surveillance and modulation of tumour progression but are burdened by immunosuppressive signals, which might vary f...
We paired high-dimensional flow cytometry, RNA sequencing and immunohistochemistry to describe the functional phenotype of T cells from healthy and neoplastic tissue of patients with primary and metas...
We found that T cells are mainly localised at the front edge and that tumor-infiltrating T cells co-express multiple inhibitory receptors, which largely differ from primary to metastatic sites. Our da...
HER-2-specific CD39 disrupted engineered T cells are promising advanced medicinal products for primary and metastatic CRC....
Optimization of cell engineering protocols requires standard, comprehensive quality metrics. We previously developed CellNet, a computational tool to quantitatively assess the transcriptional fidelity...
Manipulation of cells for applications such as biomanufacturing and cell-based therapeutics involves introducing biomolecular cargoes into cells. However, successful delivery is a function of multiple...
The programmed cell death protein 1 (PD-1) signaling pathway is a major source of dampened T cell activity in the tumor microenvironment. While clinical approaches to inhibiting the PD-1 pathway using...